146 related articles for article (PubMed ID: 20364755)
1. In vitro activity of linezolid against clinical isolates of methicillin resistant Staphylococcus.
Hannan A; Absar M; Usman M; Naeem T; Saleem S; Arshad M
J Ayub Med Coll Abbottabad; 2009; 21(1):106-9. PubMed ID: 20364755
[TBL] [Abstract][Full Text] [Related]
2. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
Efe S; Sinirtaş M; Ozakin C
Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
[TBL] [Abstract][Full Text] [Related]
3. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
4. Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006.
Shams W; Walker ES; Levy F; Reynolds SA; Peterson SM; Sarubbi FA
Chemotherapy; 2010; 56(5):411-6. PubMed ID: 20948212
[TBL] [Abstract][Full Text] [Related]
5. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
Lemaire S; Van Bambeke F; Pierard D; Appelbaum PC; Tulkens PM
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA).
Kaleem F; Usman J; Khalid A; Hassan A; Omair M
J Pak Med Assoc; 2011 Apr; 61(4):356-9. PubMed ID: 21465972
[TBL] [Abstract][Full Text] [Related]
7. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
[TBL] [Abstract][Full Text] [Related]
8. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
9. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.
Morales G; Picazo JJ; Baos E; Candel FJ; Arribi A; Peláez B; Andrade R; de la Torre MA; Fereres J; Sánchez-García M
Clin Infect Dis; 2010 Mar; 50(6):821-5. PubMed ID: 20144045
[TBL] [Abstract][Full Text] [Related]
10. Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint.
Lemaire S; Kosowska-Shick K; Appelbaum PC; Glupczynski Y; Van Bambeke F; Tulkens PM
J Antimicrob Chemother; 2011 Mar; 66(3):596-607. PubMed ID: 21186193
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263
[TBL] [Abstract][Full Text] [Related]
12. Linezolid resistance in coagulase-negative staphylococci.
Kelly S; Collins J; Davin M; Gowing C; Murphy PG
J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
[No Abstract] [Full Text] [Related]
13. Drugs for MRSA with reduced susceptibility to vancomycin.
Med Lett Drugs Ther; 2009 May; 51(1311):36; quiz 37. PubMed ID: 19417720
[No Abstract] [Full Text] [Related]
14. Linezolid-resistant methicillin-resistant Staphylococcus aureus isolated after long-term, repeated use of linezolid.
Yoshida K; Shoji H; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Fukuchi K; Adachi M; Niki Y
J Infect Chemother; 2009 Dec; 15(6):417-9. PubMed ID: 20012735
[TBL] [Abstract][Full Text] [Related]
15. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
16. MRSA--too many hurdles to overcome: a study from Central India.
Mallick SK; Basak S
Trop Doct; 2010 Apr; 40(2):108-10. PubMed ID: 20305109
[TBL] [Abstract][Full Text] [Related]
17. Comparative Efficacy of Ceftaroline with Linezolid against Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus.
Hafeez A; Munir T; Rehman S; Najeeb S; Gilani M; Latif M; Ansari M; Saad N
J Coll Physicians Surg Pak; 2015 Apr; 25(4):247-9. PubMed ID: 25899187
[TBL] [Abstract][Full Text] [Related]
18. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain.
Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H
Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857
[No Abstract] [Full Text] [Related]
19. Does linezolid modulate lung innate immunity in a murine model of methicillin-resistant Staphylococcus aureus pneumonia?
Akinnusi ME; Hattemer A; Gao W; El-Solh AA
Crit Care Med; 2011 Aug; 39(8):1944-52. PubMed ID: 21532475
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
